Brief: IntelGenx Expands Psychedelics Collaboration With atai Life Sciences
May 12 (Reuters) - IntelGenx Technologies Corp IGX.V :
* INTELGENX EXPANDS PSYCHEDELICS COLLABORATION WITH ATAI
LIFE
SCIENCES WITH SIGNING OF SECOND FEASIBILITY AGREEMENT
* INTELGENX TECHNOLOGIES CORP - UNDER SFA, WILL CONDUCT
FORMULATION DEVELOPMENT WORK TO PROVIDE A PROTOTYPE TO ATAI FOR
FURTHER CLINICAL INVESTIGATION
Source text for Eikon: ID:nGNX764kc9
Further company coverage: IGX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA